ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 40047102. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,038,000 | +5.1% | 592,954 | +2.6% | 0.01% | -8.3% |
| Q2 2016 | $988,000 | -19.8% | 578,026 | -7.6% | 0.01% | -29.4% |
| Q1 2016 | $1,232,000 | -27.5% | 625,368 | -30.1% | 0.02% | -15.0% |
| Q4 2015 | $1,700,000 | -0.5% | 894,655 | +0.0% | 0.02% | -16.7% |
| Q3 2015 | $1,708,000 | -64.2% | 894,458 | -13.1% | 0.02% | -64.2% |
| Q2 2015 | $4,774,000 | +13.1% | 1,028,771 | +6.5% | 0.07% | +1.5% |
| Q1 2015 | $4,221,000 | -25.0% | 965,994 | -40.4% | 0.07% | -22.4% |
| Q4 2014 | $5,627,000 | -13.0% | 1,621,558 | +5.1% | 0.08% | -15.0% |
| Q3 2014 | $6,468,000 | +37.4% | 1,543,560 | +92.1% | 0.10% | +37.0% |
| Q2 2014 | $4,709,000 | +549.5% | 803,615 | +598.5% | 0.07% | +508.3% |
| Q1 2014 | $725,000 | -54.0% | 115,055 | -61.5% | 0.01% | -60.0% |
| Q3 2013 | $1,575,000 | – | 298,894 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|